Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Oct;59(10):1290-1292.
doi: 10.1111/ijd.15104. Epub 2020 Aug 9.

Grover-like skin eruption: another cutaneous manifestation in a COVID-19 patient

Affiliations
Case Reports

Grover-like skin eruption: another cutaneous manifestation in a COVID-19 patient

Julian Boix-Vilanova et al. Int J Dermatol. 2020 Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical presentation at the outpatient consults. (a) Clinical image of the patient's skin lesions with multiple erythematous papules with central erosion and crusts located in the upper body. (b) “Macro” of the papules. (c) Dermatoscopic image, showing a central oval erosion with yellowish areas surrounded by a thin whitish halo
Figure 2
Figure 2
Histopathological findings. (a) Hematoxylin‐eosin x2: punch biopsy. Hematoxylin‐eosin x40: (b) exoserosis acantholysis and dyskeratotic cells with irregular nucleus surrounded by clear halo enclosed in eosinophilic shell; (c) perivascular lymphocytic infiltration with some eosinophils in the upper dermis. Immunohistochemical study for SARS‐CoV‐2 shows distinct granular positivity in (d) the endothelium of dermal vessels; (e) sweat gland epithelium

Similar articles

Cited by

References

    1. Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183: 71–77. - PMC - PubMed
    1. Marzano AV, Cassano N, Genovese G, et al. Cutaneous manifestations in patients with COVID‐19: a preliminary review of an emerging issue. Br J Dermatol 2020. 10.1111/bjd.19264. [Published online ahead of print, 2020 Jun 1]. - DOI - PMC - PubMed
    1. Gianotti R, Recalcati S, Fantini F, et al. Histopathological study of a broad spectrum of skin dermatoses in patients affected or highly suspected of infection by COVID‐19 in the northern part of Italy: analysis of the many faces of the viral‐induced skin diseases in previous and new reported cases. Am J Dermatopathol 2020; 42: 564–570. - PMC - PubMed
    1. Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID‐19 infection: a report of five cases. Transl Res 2020; 220: 1–13. - PMC - PubMed
    1. Lacarrubba F, Boscaglia S, Nasca MR, et al. Grover's disease: dermoscopy, reflectance confocal microscopy and histopathological correlation. Dermatol Pract Concept 2017; 7: 51–54. - PMC - PubMed

MeSH terms

Supplementary concepts